Assessment of the recently published Listed medicines Evidence Guidelines 

Today’s alert for members contains an assessment of the recently published Listed medicines Evidence Guidelines; a summary of CMA responses and outcomes; and a discussion of changes and issues for members to be aware of.

A full comparison highlighting the changes between the final published guidelines and the draft consultation paper is also linked for members.

We appreciate and welcome your ongoing member feedback and insights.

LinkedIn
Facebook
Twitter
Email

RECENT ARTICLES

Vale Stephen Myers

It is with great sadness that we learned of the passing of Emeritus Professor Stephen Myers late last week. Stephen was a giant in the

Read More